GGrantIndex
← Leaderboards

Robert S. Clark

University Of Pittsburgh At Pittsburgh

$12,893,742
Attributed
$20,205,574
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,205,574 · 14

By mechanism

R01$16,159,412 · 7
T32$1,682,154 · 1
R21$860,750 · 2
P50$855,374 · 2
P01$444,758 · 1
K08$203,126 · 1

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainBrain InjuriesPreventMorbidity - Disease RateIn VivoTraumatic Brain InjuryChildCell DeathAdultNeurological OutcomeIn VitroChildhoodNeuronsOxidative StressCessation Of LifeRattusFemaleDoseNeuronal SurvivalMaleMitochondriaApoptosisTraumaNeuron Loss

Grant awards (56)

Bio-digital Rapid Alert to Identify Neuromorbidity$569,740
R01 · FY2025 · NS · contact PI
Impact of microbiota-derived metabolites on traumatic brain injury-related neurodegeneration$508,868
R01 · FY2025 · NS
Pediatric Neurointensive Care and Resuscitation Research$442,788
T32 · FY2025 · HD
Bio-digital Rapid Alert to Identify Neuromorbidity$604,792
R01 · FY2024 · NS · contact PI
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia$552,190
R01 · FY2024 · NS · contact PI
Impact of microbiota-derived metabolites on traumatic brain injury-related neurodegeneration$544,922
R01 · FY2024 · NS
Pediatric Neurointensive Care and Resuscitation Research$383,109
T32 · FY2024 · HD
Bio-digital Rapid Alert to Identify Neuromorbidity$616,964
R01 · FY2023 · NS · contact PI
Impact of microbiota-derived metabolites on traumatic brain injury-related neurodegeneration$606,431
R01 · FY2023 · NS
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia$569,269
R01 · FY2023 · NS · contact PI
Pediatric Neurointensive Care and Resuscitation Research$323,028
T32 · FY2023 · HD
Bio-digital Rapid Alert to Identify Neuromorbidity$630,376
R01 · FY2022 · NS · contact PI
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia$569,269
R01 · FY2022 · NS · contact PI
Pediatric Neurointensive Care and Resuscitation Research$415,496
T32 · FY2022 · HD
Bio-digital Rapid Alert to Identify Neuromorbidity$651,658
R01 · FY2021 · NS · contact PI
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia$573,142
R01 · FY2021 · NS · contact PI
Pediatric Neurointensive Care and Resuscitation Research$117,733
T32 · FY2021 · HD
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia$592,096
R01 · FY2020 · NS · contact PI
Innovative Method for Real-time Assessment of Intracranial Compliance$430,375
R21 · FY2020 · NS · contact PI
Gut microbial metabolite-mediated neuroprotection in traumatic brain injury$430,375
R21 · FY2020 · NS
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain$392,968
R01 · FY2018 · NS · contact PI
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain$392,968
R01 · FY2017 · NS · contact PI
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain$392,968
R01 · FY2016 · NS · contact PI
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain$396,780
R01 · FY2015 · NS · contact PI
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain$405,025
R01 · FY2014 · NS · contact PI
Overcoming Membrane Transporters to Improve CNS Drug Therapy$438,499
R01 · FY2013 · NS · contact PI
Overcoming Membrane Transporters to Improve CNS Drug Therapy$462,210
R01 · FY2012 · NS · contact PI
Overcoming Membrane Transporters to Improve CNS Drug Therapy$462,178
R01 · FY2011 · NS · contact PI
Overcoming Membrane Transporters to Improve CNS Drug Therapy$462,149
R01 · FY2010 · NS · contact PI
Divergent Pathways of Cell Death after Brain Injury$378,750
R01 · FY2010 · NS · contact PI
Poly(ADP-Ribose) Polymerase and Brain Injury$147,263
P01 · FY2010 · NS · contact PI
Overcoming Membrane Transporters to Improve CNS Drug Therapy$397,030
R01 · FY2009 · NS · contact PI
Divergent Pathways of Cell Death after Brain Injury$378,750
R01 · FY2009 · NS · contact PI
Gender-Specific Treatment of Pediatric Cardiac Arrest$238,331
R01 · FY2009 · HD · contact PI
Poly(ADP-Ribose) Polymerase and Brain Injury$148,746
P01 · FY2009 · NS · contact PI
Gender-Specific Treatment of Pediatric Cardiac Arrest$238,331
R01 · FY2008 · HD · contact PI
Poly(ADP-Ribose) Polymerase and Brain Injury$148,749
P01 · FY2008 · NS · contact PI
Divergent Pathways of Cell Death after Brain Injury$330,970
R01 · FY2007 · NS · contact PI
Gender-Specific Treatment of Pediatric Cardiac Arrest$243,196
R01 · FY2007 · HD · contact PI
Poly(ADP-Ribose) Polymerase and Brain Injury$153,206
P50 · FY2007 · NS · contact PI
Divergent Pathways of Cell Death after Brain Injury$340,958
R01 · FY2006 · NS · contact PI
Gender-Specific Treatment of Pediatric Cardiac Arrest$250,460
R01 · FY2006 · HD · contact PI
Poly(ADP-Ribose) Polymerase and Brain Injury$157,152
P50 · FY2006 · NS · contact PI
Divergent Pathways of Cell Death after Brain Injury$349,266
R01 · FY2005 · NS
Gender-Specific Treatment of Pediatric Cardiac Arrest$256,488
R01 · FY2005 · HD
Divergent Pathways of Cell Death after Brain Injury$349,846
R01 · FY2004 · NS
Divergent Pathways of Cell Death after Brain Injury$348,292
R01 · FY2003 · NS
CASPASE MEDIATED NEURONAL DEATH AFTER HEAD INJURY$239,077
R01 · FY2002 · NS
PARS ACTIVATION AFTER TBI$207,281
P50 · FY2002 · NS
CASPASE MEDIATED NEURONAL DEATH AFTER HEAD INJURY$233,888
R01 · FY2001 · NS
PARS ACTIVATION AFTER TBI$207,281
P50 · FY2001 · NS
NEUROPROTECTIVE GENES AFTER TRAUMATIC BRAIN$96,163
K08 · FY2001 · NS
PARS ACTIVATION AFTER TBI$65,227
P50 · FY2001 · NS
CASPASE MEDIATED NEURONAL DEATH AFTER HEAD INJURY$190,317
R01 · FY2000 · NS
NEUROPROTECTIVE GENES AFTER TRAUMATIC BRAIN$106,963
K08 · FY2000 · NS
PARS ACTIVATION AFTER TBI$65,227
P50 · FY2000 · NS